Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun 20;2(5):247-256.
doi: 10.1002/jbm4.10055. eCollection 2018 Sep.

The Hidden Burden of Fractures in People Living With HIV

Affiliations
Review

The Hidden Burden of Fractures in People Living With HIV

Melissa O Premaor et al. JBMR Plus. .

Abstract

The survival of people living with human immunodeficiency virus (HIV) has increased markedly since the advent of antiretroviral therapy (ART). However, other morbidities have emerged, including osteoporosis. The estimated incidence of fractures at any site in people living with HIV ranges from 0.1 per 1000 person-years to 8.4 per 1000 person-years: at least twice that of people without HIV. This increased risk seems to be related to HIV itself and its treatment. Risk factors for bone disease in HIV-positive (HIV+) subjects include both classical risk factors for osteoporosis and fracture and factors linked to HIV itself, such as inflammation, reconstitution syndrome, low CD4, ART, and co-infection with hepatitis B and C viruses. The risk of fractures in these individuals can be at least partially assessed by measurement of BMD and the Fracture Risk Assessment Tool (FRAX™). Only alendronate and zoledronic acid have been studied in HIV+ individuals; both show beneficial effects on BMD, although data on fracture reduction are not available. © 2018 The Authors. JBMR Plus Published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.

Keywords: AIDS; Fracture; HIV; Osteoporosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Forest plot of the odds ratio of total fractures in HIV‐positive subjects.

Similar articles

Cited by

References

    1. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med. Feb 1993;328(5):327–35. - PubMed
    1. Palella FJ, Jr. , Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. Mar 1998;338(13):853–60. - PubMed
    1. Fang CT, Chang YY, Hsu HM, et al. Life expectancy of patients with newly‐diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM. Feb 2007;100(2):97–105. - PubMed
    1. van Sighem AI, Gras LA, Reiss P, et al. Life expectancy of recently diagnosed asymptomatic HIV‐infected patients approaches that of uninfected individuals. AIDS. Jun 2010;24(10):1527–35. - PubMed
    1. Collaboration of Observational HIVEREiE, Lewden C, Bouteloup V, et al. All‐cause mortality in treated HIV‐infected adults with CD4 >/=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol. Apr 2012;41(2):433–45. - PubMed